Grants & Awards
See below for a list of upcoming external grant opportunities related to research in dementia, stroke, and aging.
Alzheimer's Drug Discovery Foundation
Diagnostics Accelerator: Digital Biomarkers Program
Rolling applications
Diagnostics Accelerator: Peripheral Biomarkers Program
Rolling applications
Therapeutics Funding: Drug Development RFP
Letter of Intent: February 3, 2025
Invited full proposal: April 7, 2025
Therapeutics Funding: Neuroimaging and CSF Biomarker RFP
Letter of Intent: February 3, 2025
Invited full proposal: April 7, 2025
Therapeutics Funding: Prevention RFP
Letter of Intent: February 3, 2025
Invited full proposal: April 7, 2025
Brain Canada
2024 Future Leaders in Canadian Brain Research
Letter of Intent: December 2, 2024
Invited full applications: March 14, 2025
Heart and Stroke Foundation
Personnel Awards for Black Scholars
Competition closes March 20, 2025
Personnel Awards for Indigenous Scholars
Competition closes March 20, 2025
National Institutes of Health (US)- National Institute on Aging (Open to Foreign Applications/Organizations)
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
Open for submissions January 16, 2025
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
Open for submissions January 3, 2025
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
Open for submissions January 16, 2025
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
Open for submissions January 5, 2025
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional): Exploratory/Developmental Research Grant
Open for submissions February 11, 2025
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional): Research Project Grant
Open for submissions February 11, 2025
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed)
Open for submissions May 9, 2025
Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed)
Letter of Intent due January 28, 2025
Weston Family Foundation
Rapid Response 2025 Program
Program information session: February 11, 2025 at 1pm ET – Register Here
Letter of Intent due: March 18, 2025, at 2pm ET